Your Location：
Home >
Browse articles >
Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study
RESEARCH | Updated：2026-01-27

    • Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study

    • “Reporting on the latest advancements in prostate cancer detection, a multi-center study introduces its research progress in the field of AI-assisted prostate biopsy decision-making. Expert researchers established the GPT-4 system, which provides solutions to solve ambiguous biopsy decisions for patients with moderate PI-RADS scores, opening up a new direction for AI implementation in medical scenarios.”
    • Military Medical Research   Vol. 12, Issue 11, Pages: 1735-1746(2025)

    • DOI：10.1186/s40779-025-00621-3    

      CLC：

    • Received：16 August 2024，

      Accepted：12 June 2025，

      Online First：07 July 2025，

      Published：2025-11

    Scan QR Code

  • Ming-Jun Shi, Zhi-Xiang Wang, Shuang-Kun Wang, et al. Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study[J]. Military Medical Research, 2025, 12(11): 1735-1746. DOI： 10.1186/s40779-025-00621-3.

  •  
  •  

0

Views

1

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
ADP-dependent glucokinase: the ancient, archaeal key to prostate cancer
The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy
Aspartoacylase suppresses prostate cancer progres-sion by blocking LYN activation
Fracture Load Test and Spatial Analysis for the Full Scale Model of Underground Viaduct Channel Girder

Related Author

Jian Song
Jian Lu
Xuan Wei
Zhen-Chang Wang
Hao Zi
Meng-Yang Liu
Li-Sha Luo
Qiao Huang

Related Institution

Evidence-Based Medicine Center, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine
Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University
Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University
Department of Urology, Wuhan Third Hospital, Tongren Hospital of Wuhan University
Department of Forensic Medicine, Zhongnan Hospital of Wuhan University
0